TechNews

Astrocyte cholesterol helps regulate signaling at hippocampal synapses, study finds

Researchers report that cholesterol supplied by astrocytes changes how nerve cells release and recycle signaling vesicles. The laboratory finding does not establish an effect on human health.

View of Washington University in St. Louis's Danforth Campus.
File photograph of Washington University in St. Louis's Danforth Campus, taken March 29, 2019. Doc2129 (resized and converted to WebP). CC BY-SA 4.0.
LinkedInPostEmail
Save for later

Astrocytes, supporting cells in the brain, help regulate communication at hippocampal synapses by supplying cholesterol, according to a study published on 5 October 2026 in the Journal of Cell Biology. The researchers report changes in how neurons release and recycle the tiny vesicles used in signaling. The finding helps explain a cellular process, but does not show that changing cholesterol supply would improve human health.

The study, by Jongyun Myeong and Vitaly A. Klyachko, examines two linked steps in synaptic communication. Exocytosis is the release of a vesicle's contents at a connection between neurons; endocytosis recovers material so vesicles can be recycled. The authors report that cholesterol supplied by astrocytes influenced both steps. That makes the supporting cells part of the account of how a synapse responds to activity, alongside the neurons that send signals.

How astrocyte cholesterol affects synaptic vesicles

Using imaging of individual vesicle release at hippocampal synapses, the researchers examined more than whether signaling became stronger or weaker. They report that astrocytic cholesterol shifted the balance between release of a single vesicle in synchrony with a signal and release involving multiple vesicles. It also changed where release occurred across the synapse's active zone, the area where vesicles discharge their contents. Those observations describe changes in the pattern of communication at the cellular level.

On the recycling side, the authors report a change in the balance between fast and ultrafast forms of single-vesicle endocytosis. A cholesterol biosensor also indicated that signaling of cholesterol from astrocytes to neurons varied with activity. Together, the measurements led the authors to propose that astrocyte cholesterol release helps tune synaptic strength as activity changes. The reported mechanism concerns vesicle behavior at the studied synapses; it is not a measurement of memory, learning or symptoms in people.

A report provided by Washington University in St. Louis describes another result of the experiments: inhibiting astrocytes' ability to release cholesterol weakened communication between neurons. It says the researchers observed changes in the electrochemical signals at synaptic connections, making signaling less reliable. The report identifies Klyachko as a professor in the university's Department of Cell Biology & Physiology and the research lead. Its account gives a broader description of the experiments, while the study record identifies the specific release and recycling processes under examination.

Why supporting brain cells matter

Neurons make some of their own cholesterol, but the Washington University report says they do not produce enough to meet all their needs. Astrocytes also produce and release it. They support neuron development and help maintain synapses, the connections through which neurons communicate. In this study, the interest is therefore in cholesterol as part of local cell signaling, rather than the blood cholesterol measures commonly discussed in relation to cardiovascular health.

Earlier animal research gives the finding a wider context. A 2017 study published in Glia investigated astrocyte lipid metabolism in hippocampal synapse development and function in living mice, addressing a question previously studied largely in cell cultures. When the researchers reduced activity of astrocyte SREBP, a regulator of lipid production, secretion of cholesterol and phospholipids fell. The mutant mice had more immature synapses and fewer synaptic vesicles, as well as lower levels of the presynaptic protein SNAP-25 and impaired short- and long-term synaptic plasticity.

The two studies address related but distinct questions. The earlier mouse work connects astrocyte lipid metabolism with synapse development and function in an animal model. The new study focuses on how astrocyte-derived cholesterol changes the modes of vesicle release and recovery at hippocampal synapses. The 2017 findings provide a reason to study that cellular relationship, but do not establish that the precise mechanism reported in 2026 has a particular effect in people.

What the findings leave open for human health

The Washington University report notes that abnormal cholesterol levels in the brain are associated with neurological conditions including Alzheimer's disease and autism. It presents a larger role for astrocytes in those conditions as a possible research implication. The experiments reported here do not establish that astrocyte cholesterol release causes either condition, alters a person's risk or symptoms, or offers a treatment. A connection between a cellular mechanism and a disease outcome would require evidence beyond the synaptic measurements described in the available accounts.

The journal article is recorded as volume 225, issue 10, article e202512026, with DOI 10.1083/jcb.202512026. The available accounts do not give enough experimental detail to assess every method or specify sample sizes. They also do not establish whether cholesterol signaling between astrocytes and neurons works the same way in human brains. For now, the supported conclusion is narrower: at the hippocampal synapses studied, astrocyte-derived cholesterol helped regulate how signaling vesicles were released and recycled.

Sources and context

AI-assisted article checked against the listed sources. NewsJaws did not conduct interviews or attend the reported events.

About NewsJaws Desk

AI-assisted reporting and explainers reviewed against the linked source documents. No claim of on-scene reporting or original interviews.